1-Boc-4-Bromo-1H-indazole – (926922-37-4)

4, 7-Dichloroquinoline, 86-98-6, QUINOLINE, 4, 7-DICHLORO-, 4, 7-Dichloro-quinoline, MFCD00006774, Amodiaquine Impurity 1, TL 1473, NSC 593, UNII-Z61O2HEQ2J, EINECS 201-714-7, Z61O2HEQ2J, BRN 0125359, DTXSID0052590, AI3-50374, NSC-593, 1138471-54-1, DTXCID7031163, DICHLOROQUINOLINE, 4, 7-, 5-20-07-00316 (Beilstein Handbook Reference), HYDROXYCHLOROQUINE SULFATE IMPURITY G [EP IMPURITY], HYDROXYCHLOROQUINE SULFATE IMPURITY G (EP IMPURITY), 4, 7-Dichloroquinoline Quinoline, 4, 7-dichloro- NSC 593 Chloroquine Related Compound A Hydroxychloroquine Sulfate Impurity G Hydroxychloroquine Impurity G, 4, 7Dichloroquinoline, 4.7-dichloroquinoline, 4, 7 Dichloroquinoline, 47-dichloro-Quinoline, Quinoline, 7-dichloro-, 4, 7-dichloroquinolinium, Quinoline, 4, 7dichloro, BIDD:GT0207, SCHEMBL317202, 4, 7-Dichloroquinoline, 97%, CHEMBL319828, NSC593, WLN: T66 BNJ EG IG, 4, 7-Dichloroquinoline, >=99%, BCP32292, BCP32636, STR01070, Tox21_303863, AKOS000119603, CS-W020014, PS-8247, SB67463, CAS-86-98-6, NCGC00357128-01, AC-10930, AC-31966, BP-12433, HY-59243, SY001735, DB-011261, D1100, NS00004530, EN300-20302, D77863, Q27295050, F0001-2149, Z104477684, 201-714-7